Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 7/20 | 0.70 |
| ▸ | NPY1R | P25929 | 1/20 | 0.62 |
| ▸ | NPY2R | P49146 | 1/20 | 0.62 |
| ▸ | NPY4R | P50391 | 1/20 | 0.62 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.62 |
| ▸ | GLP1R | P43220 | 5/20 | 0.61 |
| ▸ | GCGR | P47871 | 3/20 | 0.61 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.61 |
| ▸ | MC4R | P32245 | 1/20 | 0.59 |
| ▸ | MC5R | P33032 | 1/20 | 0.59 |
| ▸ | MC3R | P41968 | 1/20 | 0.59 |
| ▸ | MC1R | Q01726 | 1/20 | 0.59 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.59 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.59 |
| ▸ | CTSL | P07711 | 1/20 | 0.58 |
| ▸ | CTSH | P09668 | 1/20 | 0.58 |
| ▸ | CTSS | P25774 | 1/20 | 0.58 |
| ▸ | CTSK | P43235 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29394617 | 0.99 | CXCR4 (0.71) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31182666 | 0.93 | CXCR4 (0.68) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30495596 | 0.92 | CXCR4 (0.68) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31232412 | 0.91 | NPY1R (0.68) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30658352 | 0.90 | CXCR4 (0.71) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31067646 | 0.90 | NPY1R (0.68) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31000406 | 0.90 | CXCR4 (0.70) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31000409 | 0.89 | CXCR4 (0.71) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL30658320 | 0.89 | NPY1R (0.68) | CXCR4NPY1RNPY2RNPY4RNPY5R | |
| SCHEMBL31694508 | 0.89 | CXCR4 (0.66) | CXCR4NPY1RNPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12290551-B2 | Methods for imaging and treatment of somatostatin-receptor positive tumors | CORCEPT THERAPEUTICS INCORPORATED (US) | 2025-05-06 | — | — | US | disclosed |
| US-20240307504-A1 | INTRANASAL FORMULATIONS AND DELIVERY OF SOMATOSTATIN MIMETICS AND USES THEREOF | NBO PHARMA LLC (US) | 2024-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12290551-B2 | Methods for imaging and treatment of somatostatin-receptor positive tumors | SSTR3, SSTR1, SSTR4 | CXCR4 1131/4885NPY1R 24/4885NPY2R 21/4885 |
| US-20240307504-A1 | INTRANASAL FORMULATIONS AND DELIVERY OF SOMATOSTATIN MIMETICS AND USES THEREOF | SSTR3, CRH, NPR3 | CXCR4 1482/4885NPY1R 12/4885NPY2R 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.